Health

An investigational drug called LX9211 could be the first-in-class treatment for post-herpetic neuralgia (PHN), a type of neuropathic pain that can occur after shingles. According to researcher Anand Patel, MD, of Conquest Research in Florida, the drug inhibits adapter protein 2-associated kinase-1 (AAK1), which is known to cause neuropathic pain. The drug performed well in
Alcohol use disorder (AUD) is a prevalent medical condition that can be treated with evidence-based practices. However, stigma remains a significant barrier to patients receiving the care they need. Primary care physicians must provide a welcoming and judgment-free space for patients to discuss their substance use. Normalizing discussions about alcohol use and shifting the physician-patient